CAS Medical Systems Announces First Quarter 2009 Earnings Release Date and Conference...

CAS Medical Systems Announces First Quarter 2009 Earnings Release Date and
Conference Call Information

BRANFORD, Conn., April 29, 2009 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc.
(Nasdaq:CASM) today announced that the Company will release first quarter
results for the period ended March 31, 2009 on Wednesday, May 6, 2009 before the
market opens. The Company will host a conference call that same day at 10:00
a.m. Eastern Time. Participants on the call will be Andrew Kersey, President and
CEO, and Jeffery Baird, CFO.

Date: May 6, 2009
Time: 10:00 AM ET
Listen via Internet: www.casmed.com

Please allow extra time prior to the call to visit the site and download the
streaming media software required to join the webcast. An online archive of the
webcast will be available and archived on the website for thirty days.

Telephone: 877-856-1956
Telephone: 719-325-4753
About CASMED(r) - Monitoring What's Vital

CAS Medical Systems, Inc. is a leading developer and manufacturer of medical
devices for non-invasive patient monitoring. The Company's FORE-SIGHT Absolute
Cerebral Oximeter is the first cerebral oximeter available with FDA clearance
for non-invasive, continuous measurement of absolute cerebral tissue oxygen
saturation for neonates, infants, children and adults. This information helps
avert brain damage or death during surgery and in critical care situations by
allowing clinicians to identify patients with dangerously low levels of cerebral
oxygen and intervene to reverse the condition.

The Company's product lines include the high-acuity monitoring capabilities of
the FORE-SIGHT Cerebral Oximeter, the bedside patient monitoring line of vital
signs and cardio-respiratory monitoring products, proprietary non-invasive blood
pressure measurement technology, and supplies and service including blood
pressure cuffs and products for neonatal intensive care. CASMED products are
designed to meet the needs of a full spectrum of patient populations worldwide,
ranging from adults to pediatrics and neonates.

For further information regarding CAS Medical Systems, Inc., visit the Company's
website at www.casmed.com.

Statements included in this press release, which are not historical in nature,
are forward-looking statements made pursuant to the safe harbor provisions of
the Private Securities Litigation Reform Act of 1995. Statements relating to the
future financial performance of the Company are subject to many factors
including, but not limited to, the customer acceptance of the products in the
market, the introduction of competitive products and product development,
commercialization and technological difficulties, the impact of actions and
events involving key customers and vendors, and other risks detailed in the
Company's Form 10-K for the year ended December 31, 2008 and other subsequent
Securities and Exchange Commission filings. Such statements are based upon the
current beliefs and expectations of the Company's management and are subject to
significant risks and uncertainties. Actual results may differ from those set
forth in the forward-looking statements. When used in this press release the
terms "anticipate", "believe", "estimate", "expect", "may", "objective", "plan",
"possible", "potential", "project", "will" and similar expressions identify
forward-looking statements. The forward-looking statements contained in this
press release are made as of the date hereof, and we do not undertake any
obligation to update any forward-looking statements, whether as a result of
future events, new information or otherwise.

-0-
CONTACT: CAS Medical Systems, Inc.
Susan Carron, Director of Corporate Communications
203-488-6056
ir@casmed.com